World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
73
Citations
27393
World Ranking
1931
National Ranking
1132

Matthew W. Johnson publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Matthew W. Johnson sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 187 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Matthew W. Johnson D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Matthew W. Johnson sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 73 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow of the American Psychological Association (APA)

Overview

Matthew W. Johnson is affiliated with the Johns Hopkins University School of Medicine in the United States. Their research primarily focuses on psychological and pharmacological studies with a strong emphasis on the effects and therapeutic potential of psychedelics, particularly psilocybin.

Johnson's recent published papers include:

  • Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder, 2020, JAMA Psychiatry
  • Single-Dose Psilocybin Treatment for Major Depressive Disorder, 2023, JAMA
  • Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up, 2022, Journal of Psychopharmacology
  • Rejecting impulsivity as a psychological construct: A theoretical, empirical, and sociocultural argument, 2020, Psychological Review
  • Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey, 2020, Frontiers in Psychiatry

Their frequent co-authors reflect collaborations in overlapping domains of psychology and psychopharmacology and include:

  • Justin C. Strickland
  • Albert Garcia-Romeu
  • Roland R. Griffiths
  • Derek D. Reed
  • Brett W. Gelino

Johnson has contributed extensively to several scholarly venues, indicating a broad engagement with both general and specialized fields. Frequent publication venues include:

  • Journal of Psychopharmacology
  • Experimental and Clinical Psychopharmacology
  • Archives of Sexual Behavior
  • Drug and Alcohol Dependence
  • Frontiers in Psychiatry

Their main fields of study center on psychology, with particular attention to clinical applications. Subfields covered include:

  • Clinical Psychology
  • Organic Chemistry
  • Cellular and Molecular Neuroscience
  • Applied Psychology
  • General Decision Sciences

The central research topics encompass areas related to psychedelic substances and their effects, as well as behavioral and biochemical aspects, including:

  • Psychedelics and Drug Studies
  • Chemical synthesis and alkaloids
  • Neurotransmitter Receptor Influence on Behavior
  • Decision-Making and Behavioral Economics
  • Behavioral Health and Interventions
  • Biochemical Analysis and Sensing Techniques
  • Adolescent Sexual and Reproductive Health

Among recognized distinctions, Matthew W. Johnson was named a Fellow of the American Psychological Association (APA) in 2016. This acknowledgment reflects their contributions to the field of psychology at large.

Best Publications

  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

    Roland R Griffiths;Matthew W Johnson;Michael A Carducci;Annie Umbricht

  • Human hallucinogen research: guidelines for safety.

    Matthew W. Johnson;William A. Richards;Roland R. Griffiths

  • Within-subject comparison of real and hypothetical money rewards in delay discounting.

    Matthew W. Johnson;Warren K. Bickel

  • Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial

    Alan K. Davis;Alan K. Davis;Frederick S. Barrett;Darrick G. May;Mary P. Cosimano

  • Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

    Roland R. Griffiths;William A. Richards;Matthew W. Johnson;Una D. McCann

  • Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction

    Matthew W Johnson;Albert Garcia-Romeu;Mary P Cosimano;Roland R Griffiths

  • Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

    Roland R. Griffiths;Matthew W. Johnson;William A. Richards;Brian D. Richards

  • Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

    Katherine A MacLean;Matthew W Johnson;Roland R Griffiths

  • Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude.

    Forest Baker;Matthew W. Johnson;Warren K. Bickel

  • Long-term Follow-Up of Psilocybin-Facilitated Smoking Cessation

    Matthew W. Johnson;Albert Garcia-Romeu;Roland R. Griffiths

  • The Behavioral Economics of Substance Use Disorders: Reinforcement Pathologies and Their Repair

    Warren K. Bickel;Matthew W. Johnson;Mikhail N. Koffarnus;James MacKillop

  • Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.

    Frederick S Barrett;Matthew W Johnson;Roland R Griffiths

  • Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.

    Theresa M Carbonaro;Matthew P Bradstreet;Frederick S Barrett;Katherine A MacLean

  • An algorithm for identifying nonsystematic delay-discounting data.

    Matthew W. Johnson;Warren K. Bickel

  • Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction

    Albert Garcia-Romeu;Roland R. Griffiths;Matthew W. Johnson

  • Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.

    Matthew W. Johnson;Peter S. Hendricks;Frederick S. Barrett;Roland R. Griffiths

  • Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

    Roland R Griffiths;Matthew W Johnson;William A Richards;Brian D Richards

  • Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

    Unknown

  • Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.

    Katherine A. MacLean;Jeannie Marie S. Leoutsakos;Matthew W. Johnson;Roland R. Griffiths

  • Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

    Peter S Hendricks;Christopher B Thorne;C Brendan Clark;David W Coombs

  • Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybin

    Frederick S. Barrett;Matthew W. Johnson;Roland R. Griffiths

Frequent Co-Authors

Roland R. Griffiths
Roland R. Griffiths Johns Hopkins University School of Medicine
Warren K. Bickel
Warren K. Bickel Virginia Tech
Justin C. Strickland
Justin C. Strickland Johns Hopkins University
Richard Yi
Richard Yi University of Kansas
Peter S. Hendricks
Peter S. Hendricks University of Alabama at Birmingham
Nancy Glass
Nancy Glass Johns Hopkins University
Fred M. Ssewamala
Fred M. Ssewamala New York University
Carl A. Latkin
Carl A. Latkin Johns Hopkins University
Gary J. Badger
Gary J. Badger University of Vermont
F. Joseph McClernon
F. Joseph McClernon Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in psychology opens doors to a variety of career pathways, many of which can be started or advanced through online study. Mental health counseling is a popular choice, but there are specific requirements depending on your location. For example, you can learn more about the mental health counselor requirements in Austin to understand what qualifications, licensing, and training are necessary in Texas.

Education standards also differ by city and state. If you’re exploring opportunities in California, review the Bakersfield mental health counselor education requirements to see what academic and practical experience you’ll need. Similarly, aspiring counselors in Maryland can check how to become a mental health counselor in Baltimore to plan their academic pathway.

For those interested in opportunities in Idaho, read about how to become a mental health counselor in Boise. Online degree programs in psychology and related fields provide flexible options to meet these requirements and help prepare students for licensure, internships, and long-term career success.

Best Scientists Citing Matthew W. Johnson

Trending Scientists

Recently Published Articles